Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 64 (7), 1147-50

Regulation of Anandamide Tissue Levels by N-arachidonylglycine

Affiliations

Regulation of Anandamide Tissue Levels by N-arachidonylglycine

Sumner H Burstein et al. Biochem Pharmacol.

Abstract

N-arachidonylglycine (NAGly), the carboxylic analog of the endocannabinoid anandamide, occurs in rat and bovine brain as well as in peripheral sites and shows activity against tonic, formalin-induced pain. It was also observed, using cell membrane preparations, that it inhibits the hydrolytic activity of fatty acid amide hydrolase (FAAH) on anandamide (N-arachidonylethanolamide). These data suggested that it may serve as an endogenous regulator of tissue anandamide concentrations. In this report, we show findings derived from mass spectrometric analyses, indicating that blood levels of anandamide in rats given 10 mg/kg p.o. of NAGly were increased significantly by more than 9-fold when compared with vehicle-treated controls. In vitro evidence in RAW 264.7 cells using a deuterium-labeled NAGly demonstrated that it was not a precursor or source of arachidonic acid for the observed 50% rise in anandamide levels, suggesting that the increase was due to some effect other than increased biosynthesis of anandamide. Moreover, the findings presented here suggest that NAGly can serve as a model for the design of agents to provide pharmacological control of tissue anandamide concentrations.

Similar articles

See all similar articles

Cited by 22 PubMed Central articles

See all "Cited by" articles

Publication types

LinkOut - more resources

Feedback